Previous 10 | Next 10 |
Accolade (ACCD) prices its underwritten public offering of 5M common shares at $38.50 per share.Underwriters have an option to purchase up to 750,000 additional common shares. Closing date is October 26, 2020.Net proceeds will be used for general corporate purposes, including working capital,...
SEATTLE, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (“Accolade”), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, today announced the pricing of its pr...
Accolade (ACCD) commenced an underwritten public offering of 4.50M common stock; expects to grant to the underwriters a 30-day option to purchase an additional 675K of the shares to cover over-allotments.The public offering price has not yet been determined.Net proceeds from the pro...
SEATTLE, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (“Accolade”), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, today announced it has filed a regist...
The following slide deck was published by Accolade, Inc. in conjunction with their 2020 Q2 earnings call. For further details see: Accolade, Inc. 2020 Q2 - Results - Earnings Call Presentation
Image source: The Motley Fool. Accolade Inc (NASDAQ: ACCD) Q2 2021 Earnings Call Oct 14, 2020 , 5:00 p.m. ET Continue reading For further details see: Accolade Inc Q2 2021 Earnings Call Transcript
Accolade, Inc. (ACCD) Q2 2021 Earnings Conference Call Oct 14, 2020, 05:00 PM ET Company Participants Todd Friedman - Senior VP, IR Rajeev Singh - CEO Steve Barnes - CFO Shantanu Nundy - Chief Medical Officer Conference Call Participants Sean Wieland - Piper Sandler Bob Jones - Goldman Sachs ...
Accolade (ACCD): FQ2 GAAP EPS of -$0.47 beats by $0.11.Revenue of $36.8M (+23.9% Y/Y) beats by $1.81M.Press Release For further details see: Accolade EPS beats by $0.11, beats on revenue
Fiscal second quarter 2021 revenue of $36.8 million, a 24% increase compared to fiscal second quarter 2020 revenue of $29.7 million, driven primarily by strength in new customer adds across segments and offerings Continued bookings momentum driving strength in new customer adds across...
Accolade partners with the Global Appropriateness Measures group to bring data-driven insights on provider matching to employers 55% of Americans say they'd seek help from a medical professional more often if the right one - and a good fit - was easy to find [1] PR Newswire ...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / July 21, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...